Trial intelligence / Profile preview

Remimazolam tosylate versus propofol for sedation in painless gastroscopy/colonoscopy

ChiCTR2000035813Phase 4Recruiting

Sponsor
Anhui Provincial Tumor Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Remimazolam tosylate group with Propofol group (2 arms). Primary endpoint: MOAA/S score. Started Aug 2020; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2000035813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call